In the news
KSM study: Immunity against COVID-19 among children many months after infection.
Our new study on the duration of protection conferred by a previous SARS-CoV-2 infection amongst children and adolescents.
Effectiveness of the 4th dose of Pfizer’s COVID-19 vaccine wanes after 10 weeks, sooner than previous doses.
The 4th dose of the BNT162b2 vaccine provides at least 73% protection against SARS-CoV-2 severe illness relative to three doses.
Minimizing treatment-induced emergence of antibiotic resistance in bacterial infections.